Cover Image
Market Research Report

Global NK Cell Therapy Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application

Published by QYResearch Product code 906175
Published Content info 97 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global NK Cell Therapy Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application
Published: August 13, 2019 Content info: 97 Pages
Description

To date, they have generated minimal revenue related to the non-clinical use of their cell lines and intellectual property. They have no products approved for commercial sale and have not generated any revenue from product sales.

The global natural killer cells therapeutics market was valued at $216.219 million in 2018, and is projected to reach $626.769 million by 2025, registering a CAGR of 16.4% from 2018 to 2025.

This report studies the NK Cell Therapy market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; this report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

This report focuses on the global top players, covered

Nektar Therapeutics

Innate Pharma SA

Affimed

Chipscreen Biosciences

Fate Therapeutics

Glycostem Therapeutics

Dragonfly Therapeutics

Kiadis Pharma

NantWorks

Nkarta Therapeutics

Fortress Biotech

Market segment by Regions/Countries, this report covers:

North America

Europe

Asia

RoW

Market segment by Type, the product can be split into:

NK Cell Therapies

NK Cell Directed Antibodies

Market segment by Application, the market can be split into:

Cancer

Gastrointestinal Diseases

Others

Table of Contents

Table of Contents

1 Market Overview of NK Cell Therapy 1

  • 1.1 NK Cell Therapy Market Overview 1
    • 1.1.1 NK Cell Therapy Product Scope 1
    • 1.1.2 NK Cell History 1
    • 1.1.3 Market Status and Outlook 2
  • 1.2 Global NK Cell Therapy Market Size and Analysis by Regions (2014-2019) 3
    • 1.2.1 North America 4
    • 1.2.2 Europe 5
    • 1.2.3 Asia 5
    • 1.2.4 Rest of World 6
  • 1.3 NK Cell Therapy Market by Type 6
    • 1.3.1 Global NK Cell Therapy Revenue (M USD) and Growth Comparison by Type (2014-2025) 7
    • 1.3.2 Global NK Cell Therapy Revenue Market Share by Type in 2018 7
    • 1.3.3 NK Cell Therapies 8
    • 1.3.4 NK Cell Directed Antibodies 9
  • 1.4 NK Cell Therapy Market by End Users/Application 9
    • 1.4.1 Cancer 10
    • 1.4.2 Gastrointestinal Diseases 11

2 Global NK Cell Therapy Competition Analysis by Players 13

  • 2.1 Global NK Cell Therapy Market Size (M USD) by Players (2014-2019) 13
  • 2.2 Competitive Status 16
    • 2.2.1 Market Concentration Rate 16
    • 2.2.2 Product/Service Differences 17
    • 2.2.3 Mergers & Acquisitions, Expansion Plans 18

3 Company (Top Players) Profiles and Key Data 20

  • 3.1 Nektar Therapeutics 20
    • 3.1.1 Nektar Therapeutics Profile 20
    • 3.1.2 Nektar Therapeutics Main Business/Business Overview 20
    • 3.1.3 Nektar Therapeutics NK Cell Therapy Products, Services and Solutions 21
      • 3.1.3.1 Bempegaldesleukin(NKTR-214) 21
      • 3.1.3.2 NKTR-262 22
      • 3.1.3.3 NKTR-255 23
    • 3.1.4 Nektar Therapeutics NK Cell Therapy Revenue (M USD) (2018-2019) 23
    • 3.1.5 Nektar Therapeutics Recent Developments 24
  • 3.2 Innate Pharma SA 24
    • 3.2.1 Innate Pharma SA Profile 24
    • 3.2.2 Innate Pharma SA Main Business/Business Overview 25
    • 3.2.3 Innate Pharma SA NK Cell Therapy Products, Services and Solutions 25
      • 3.2.3.1 Monalizumab (Previously IPH2201) 25
      • 3.2.3.2 NKP46 NKCE 26
      • 3.2.3.3 IPH4102 26
    • 3.2.4 Innate Pharma SA NK Cell Therapy Revenue (M USD) (2018-2019) 27
    • 3.2.5 Innate Pharma SA Recent Developments 27
  • 3.3 Affimed NV 27
    • 3.3.1 Affimed NV Profile 27
    • 3.3.2 Affimed NV Main Business/Business Overview 28
    • 3.3.3 Affimed NV NK Cell Therapy Products, Services and Solutions 28
      • 3.3.3.1 AFM13 28
      • 3.3.3.2 AFM24 28
      • 3.3.3.3 AFM26 (partnered) 29
    • 3.3.4 Affimed NV NK Cell Therapy Revenue (M USD) (2018-2019) 29
    • 3.3.5 Affimed NV Recent Developments 29
  • 3.4 Chipscreen Biosciences 30
    • 3.4.1 Chipscreen Biosciences Profile 30
    • 3.4.2 Chipscreen Biosciences Main Business/Business Overview 30
    • 3.4.3 Chipscreen Biosciences NK Cell Therapy Products, Services and Solutions 31
    • 3.4.4 Chipscreen Biosciences NK Cell Therapy Revenue (M USD) (2018-2019) 32
    • 3.4.5 Chipscreen Biosciences Recent Developments 32
  • 3.5 Fate Therapeutics 32
    • 3.5.1 Fate Therapeutics Profile 32
    • 3.5.2 Fate Therapeutics Main Business/Business Overview 33
    • 3.5.3 Fate Therapeutics NK Cell Therapy Products, Services and Solutions 33
      • 3.5.3.1 FT500 33
      • 3.5.3.2 NK100 33
    • 3.5.4 Fate Therapeutics NK Cell Therapy Revenue (M USD) (2018-2019) 34
    • 3.5.5 Fate Therapeutics Recent Developments 34
  • 3.6 Glycostem Therapeutics 34
    • 3.6.1 Glycostem Therapeutics Profile 34
    • 3.6.2 Glycostem Therapeutics Main Business/Business Overview 35
    • 3.6.3 Glycostem Therapeutics NK Cell Therapy Products, Services and Solutions 35
    • 3.6.4 Glycostem Therapeutics NK Cell Therapy Revenue (M USD) (2018-2019) 36
    • 3.6.5 Glycostem Therapeutics Recent Developments 36
  • 3.7 Dragonfly Therapeutics 37
    • 3.7.1 Dragonfly Therapeutics Profile 37
    • 3.7.2 Dragonfly Therapeutics Main Business/Business Overview 37
    • 3.7.3 Dragonfly Therapeutics NK Cell Therapy Products, Services and Solutions 37
    • 3.7.4 Dragonfly Therapeutics NK Cell Therapy Revenue (M USD) (2018-2019) 38
    • 3.7.5 Dragonfly Therapeutics Recent Developments 38
  • 3.8 Kiadis Pharma 38
    • 3.8.1 Kiadis Pharma Profile 38
    • 3.8.2 Kiadis Pharma Main Business/Business Overview 39
    • 3.8.3 Kiadis Pharma NK Cell Therapy Products, Services and Solutions 39
    • 3.8.4 Kiadis Pharma NK Cell Therapy Revenue (M USD) (2018-2019) 39
    • 3.8.5 Kiadis Pharma Recent Developments 40
  • 3.9 NantWorks 40
    • 3.9.1 NantWorks Profile 40
    • 3.9.2 NantWorks Main Business/Business Overview 40
    • 3.9.3 NantWorks NK Cell Therapy Products, Services and Solutions 41
    • 3.9.4 NantWorks NK Cell Therapy Revenue (M USD) (2018-2019) 42
    • 3.9.5 NantWorks Recent Developments 42
  • 3.10 Nkarta Therapeutics 42
    • 3.10.1 Nkarta Therapeutics Profile 42
    • 3.10.2 Nkarta Therapeutics Main Business/Business Overview 43
    • 3.10.3 Nkarta Therapeutics NK Cell Therapy Products, Services and Solutions 43
    • 3.10.4 Nkarta Therapeutics NK Cell Therapy Revenue (M USD) (2018-2019) 44
    • 3.10.5 Nkarta Therapeutics Recent Developments 44
  • 3.11 Fortress Biotech 44
    • 3.11.1 Fortress Biotech Profile 44
    • 3.11.2 Fortress Biotech Main Business/Business Overview 45
    • 3.11.3 Fortress Biotech NK Cell Therapy Products, Services and Solutions 45
    • 3.11.4 Fortress Biotech NK Cell Therapy Revenue (M USD) (2018-2019) 45
    • 3.11.5 Fortress Biotech Recent Developments 46

4 Global NK Cell Therapy Market Size by Application (2014-2019) 47

  • 4.1 Global NK Cell Therapy Market Size by Application (2014-2019) 47
  • 4.2 Global NK Cell Therapy Market Growth by Application 49
  • 4.3 Potential Application of NK Cell Therapy in Future 49

5 North America NK Cell Therapy Development Status and Outlook 50

  • 5.1 North America NK Cell Therapy Market Size (2014-2019) 50
  • 5.2 North America NK Cell Therapy Market Size and Market Share by Players (2018-2019) 50
  • 5.3 North America NK Cell Therapy Market Size by Application (2014-2019) 52

6 Europe NK Cell Therapy Development Status and Outlook 53

  • 6.1 Europe NK Cell Therapy Market Size (2014-2019) 53
  • 6.2 Europe NK Cell Therapy Market Size and Market Share by Players (2018-2019) 53
  • 6.3 Europe NK Cell Therapy Market Size by Application (2014-2019) 54

7 Asia NK Cell Therapy Development Status and Outlook 56

  • 7.1 Asia NK Cell Therapy Market Size and Forecast (2014-2019) 56
  • 7.2 Asia NK Cell Therapy Market Size and Market Share by Players (2018-2019) 56
  • 7.3 Asia NK Cell Therapy Market Size by Application (2014-2019) 57

8 Rest of World NK Cell Therapy Development Status and Outlook 59

  • 8.1 Rest of World NK Cell Therapy Market Size (2014-2019) 59
  • 8.2 Rest of World NK Cell Therapy Market Size by Application (2014-2019) 59

9 Global NK Cell Therapy Market Size by Type (2014-2019) 61

  • 9.1 Global NK Cell Therapy Market Size by Type (2014-2019) 61
  • 9.2 Global NK Cell Therapy Market Growth by Type 62

10 T-cell Therapy and NK Cell Therapy 64

  • 10.1 Cell Therapy Overview 64
  • 10.2 T-cell Therapy Overview 64
  • 10.3 CAR-NK Cells' Advantages over CAR-T Cells 64
  • 10.4 Source of the NK Cells 65

11 Market Forecast by Regions, Product and Application (2019-2025) 66

  • 11.1 Global NK Cell Therapy Market Size by Regions (2019-2025) 66
    • 11.1.1 North America NK Cell Therapy Revenue and Growth Rate (2019-2025) 69
    • 11.1.2 Europe NK Cell Therapy Revenue and Growth Rate (2019-2025) 70
    • 11.1.3 Asia NK Cell Therapy Revenue and Growth Rate (2019-2025) 71
    • 11.1.4 Rest of World NK Cell Therapy Revenue and Growth Rate (2019-2025) 72
  • 11.2 Global NK Cell Therapy Market Size by Application (2019-2025) 72
  • 11.3 Global NK Cell Therapy Market Size by Type (2019-2025) 74

12 NK Cell Therapy Market Dynamics 76

  • 12.1 Industry Trends 76
  • 12.2 Market Drivers 76
  • 12.3 Market Challenges 77
  • 12.4 Porter's Five Forces Analysis 77
  • 12.5 NK Cell Developers Analysis 78

13 Research Finding /Conclusion 80

14 Methodology and Data Source 81

  • 14.1 Methodology/Research Approach 81
    • 14.1.1 Research Programs/Design 81
    • 14.1.2 Market Size Estimation 82
    • 14.1.3 Market Breakdown and Data Triangulation 83
  • 14.2 Data Source 85
    • 14.2.1 Secondary Sources 85
    • 14.2.2 Primary Sources 85
  • 14.3 Disclaimer 86
  • 14.4 Author List 87

List of Tables and Figures

  • Figure NK Cell Therapy Picture 1
  • Figure Global NK Cell Therapy Market Size (M USD) Status and Outlook (2014-2025) 3
  • Table Global Market NK Cell Therapy Revenue (M USD) Comparison by Regions 2019-2025 3
  • Figure Global NK Cell Therapy Market Share by Regions (2014-2019) 4
  • Figure North America NK Cell Therapy Market Size (M USD) and Growth Rate (2014-2025) 4
  • Figure Europe NK Cell Therapy Market Size (M USD) and Growth Rate (2014-2025) 5
  • Figure Asia NK Cell Therapy Market Size (M USD) and Growth Rate (2014-2025) 5
  • Figure Rest of World NK Cell Therapy Market Size (M USD) and Growth Rate (2014-2025) 6
  • Table Global NK Cell Therapy Revenue (M USD) and Growth Rate Comparison by Type (2019-2025) 7
  • Figure Global NK Cell Therapy Market Share by Type in 2018 & 2025 7
  • Figure NK Cell Therapies Market Size (M USD) and Growth Rate (2014-2019) 8
  • Figure NK Cell Directed Antibodies Market Size (M USD) and Growth Rate (2014-2019) 9
  • Table Global NK Cell Therapy Market Size (M USD) Comparison by Application (2019-2025) 9
  • Figure Global NK Cell Therapy Market Share by Application in 2018 & 2025 10
  • Figure NK Cell Therapy Market Size (M USD) and Growth Rate in Cancer (2014-2019) 11
  • Figure NK Cell Therapy Market Size (M USD) and Growth Rate in Gastrointestinal Diseases (2014-2019) 12
  • Table Global NK Cell Therapy Revenue (M USD) by Players (2018-2019) 13
  • Table Global NK Cell Therapy Revenue Market Share by Players (2018-2019) 14
  • Figure Global NK Cell Therapy Market Size Share by Players in 2018 15
  • Figure Global NK Cell Therapy Market Size Share by Players in 2019 16
  • Table Global NK Cell Therapy Manufacturers Market Concentration Ratio 16
  • Figure Global Top 5 Players NK Cell Therapy Market Share in 2018 17
  • Figure Global Top 10 Players NK Cell Therapy Market Share in 2018 17
  • Table NK Cell Therapy Key Players Product/Service 17
  • Table Nektar Therapeutics Basic Information List 20
  • Table Bempegaldesleukin(NKTR-214)Pipeline 21
  • Table Revenue (M USD) in NK Cell Therapy Business of Nektar Therapeutics (2018-2019) 23
  • Table Nektar Therapeutics Recent Developments 24
  • Table Innate Pharma SA Basic Information List 24
  • Figure Mechanism of Action of Anti-NKG2A Picture 25
  • Table Revenue (M USD) in NK Cell Therapy Business of Innate Pharma SA (2018-2019) 27
  • Table Innate Pharma SA Recent Developments 27
  • Table Affimed NV Basic Information List 27
  • Table Revenue (M USD) in NK Cell Therapy Business of Affimed NV (2018-2019) 29
  • Table Affimed NV Recent Developments 29
  • Figure Affimed NV Recent Developments 30
  • Table Chipscreen Biosciences Basic Information List 30
  • Figure Chidamide Picture 31
  • Table Revenue (M USD) in NK Cell Therapy Business of Chipscreen Biosciences (2018-2019) 32
  • Table Fate Therapeutics Basic Information List 32
  • Table Revenue (M USD) in NK Cell Therapy Business of Fate Therapeutics (2018-2019) 34
  • Table Fate Therapeutics Recent Developments 34
  • Table Glycostem Therapeutics Basic Information List 34
  • Figure Phase I Study of oNKord 36
  • Table Revenue (M USD) in NK Cell Therapy Business of Glycostem Therapeutics (2018-2019) 36
  • Table Dragonfly Therapeutics Basic Information List 37
  • Table Revenue (M USD) in NK Cell Therapy Business of Dragonfly Therapeutics (2018-2019) 38
  • Figure Dragonfly Therapeutics Recent Developments 38
  • Table Kiadis Pharma Basic Information List 38
  • Table Revenue (M USD) in NK Cell Therapy Business of Kiadis Pharma (2018-2019) 39
  • Table NantWorks Basic Information List 40
  • Table Revenue (M USD) in NK Cell Therapy Business of NantWorks (2018-2019) 42
  • Table NantWorks Recent Developments 42
  • Table Nkarta Therapeutics Basic Information List 42
  • Table Revenue (M USD) in NK Cell Therapy Business of Nkarta Therapeutics (2018-2019) 44
  • Table Fortress Biotech Basic Information List 44
  • Table Revenue (M USD) in NK Cell Therapy Business of Fortress Biotech (2018-2019) 45
  • Table Global NK Cell Therapy Market Size by Application (2014-2019) (M USD) 47
  • Table Global NK Cell Therapy Market Share by Application (2014-2019) 47
  • Figure Global NK Cell Therapy Revenue Market Share by Application (2014-2019) 48
  • Figure Global NK Cell Therapy Market Size Share by Application in 2018 48
  • Table Global NK Cell Therapy Market Growth by Application (2014-2019) 49
  • Figure Global NK Cell Therapy Market Growth by Application (2014-2019) 49
  • Figure North America NK Cell Therapy Market Size and Growth Rate (2014-2019) (M USD) 50
  • Table North America NK Cell Therapy Market Size by Players (2018-2019) (M USD) 50
  • Table North America NK Cell Therapy Market Size Share by Players (2018-2019) 51
  • Figure North America NK Cell Therapy Market Size Share by Players in 2018 51
  • Table North America NK Cell Therapy Market Size by Application (2014-2019) (M USD) 52
  • Table North America NK Cell Therapy Market Size Share by Application (2014-2019) 52
  • Figure North America NK Cell Therapy Market Size Share by Application in 2018 52
  • Figure Europe NK Cell Therapy Market Size and Growth Rate (2014-2019) (M USD) 53
  • Table Europe NK Cell Therapy Market Size by Players (2018-2019) (M USD) 53
  • Table Europe NK Cell Therapy Market Size Share by Players (2018-2019) 54
  • Figure Europe NK Cell Therapy Market Size Share by Players in 2018 54
  • Table Europe NK Cell Therapy Market Size by Application (2014-2019) (M USD) 54
  • Table Europe NK Cell Therapy Revenue Market Share by Application (2014-2019) 55
  • Figure Europe NK Cell Therapy Market Size Share by Application in 2018 55
  • Figure Asia NK Cell Therapy Market Size and Growth Rate (2014-2019) (M USD) 56
  • Table Asia NK Cell Therapy Market Size by Players (2018-2019) (M USD) 56
  • Figure Asia NK Cell Therapy Market Size Share by Players in 2018 57
  • Table Asia NK Cell Therapy Market Size by Application (2014-2019) (M USD) 57
  • Table Asia NK Cell Therapy Revenue Market Share by Application (2014-2019) 57
  • Figure Asia NK Cell Therapy Market Size Share by Application in 2018 58
  • Figure Rest of World NK Cell Therapy Market Size and Growth Rate (2014-2019) (M USD) 59
  • Table Rest of World NK Cell Therapy Market Size by Application (2014-2019) (M USD) 59
  • Table Rest of World NK Cell Therapy Revenue Market Share by Application (2014-2019) 60
  • Figure Rest of World NK Cell Therapy Market Size Share by Application in 2018 60
  • Table Global NK Cell Therapy Market Size by Type (2014-2019) (M USD) 61
  • Table Global NK Cell Therapy Market Share by Type (2014-2019) 61
  • Figure Global NK Cell Therapy Revenue Market Share by Type (2014-2019) 61
  • Figure Global NK Cell Therapy Market Size Share by Type in 2018 62
  • Table Global NK Cell Therapy Market Growth by Type (2014-2019) 62
  • Figure Global NK Cell Therapy Market Growth by Type (2014-2019) 63
  • Figure Global NK Cell Therapy Market Size and Growth Rate (Value) (2019-2025) (M USD) 66
  • Table Global NK Cell Therapy Market Size by Regions (2019-2025) (M USD) 66
  • Table Global NK Cell Therapy Market Share by Regions (2019-2025) 67
  • Figure Global NK Cell Therapy Market Size Share by Regions (2019-2025) 67
  • Figure Global NK Cell Therapy Market Size Share by Regions in 2025 68
  • Figure North America NK Cell Therapy Revenue (M USD) and Growth Rate (2019-2025) 69
  • Figure Europe NK Cell Therapy Revenue (M USD) and Growth Rate (2019-2025) 70
  • Figure Asia NK Cell Therapy Revenue (M USD) and Growth Rate (2019-2025) 71
  • Figure Rest of World NK Cell Therapy Revenue (M USD) and Growth Rate (2019-2025) 72
  • Table Global NK Cell Therapy Market Size by Application (2019-2025) (M USD) 72
  • Table Global NK Cell Therapy Market Share by Application (2019-2025) 72
  • Figure Global NK Cell Therapy Market Share by Application (2019-2025) 73
  • Figure Global NK Cell Therapy Market Size by Application in 2025 73
  • Table Global NK Cell Therapy Market Size by Type (2019-2025) (M USD) 74
  • Figure Global NK Cell Therapy Market Size by Type (2019-2025) 74
  • Figure Global NK Cell Therapy Market Size by Type in 2025 75
  • Table Market Top Trends 76
  • Figure Porter's Five Forces Analysis 78
  • Table NK Cell Developers Analysis 78
  • Table Research Programs/Design for This Report 81
  • Figure Bottom-up and Top-down Approaches for This Report 83
  • Figure Data Triangulation 84
  • Table Key Data Information from Secondary Sources 85
  • Table Key Data Information from Primary Sources 86
Back to Top